Skip to content
Disclosery

Paradigm Biocapital Advisors LP: TARS position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Paradigm Biocapital Advisors LP on TARS, newest first. How the timeline and the estimate are built.

Paradigm Biocapital Advisors LP held 2,775,649 TARS shares at 2026-06-30 per its 13F-HR filed 2026-08-14.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 2,775,649 shares
    Change vs previous 13F +213,495 shares

    3.27% of the 13F portfolio, value $174,699,348.

    13F-HR 0001855655-26-000014 filed by Paradigm Biocapital Advisors LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 2,562,154 shares
    Change vs previous 13F 0 shares

    3.67% of the 13F portfolio, value $179,735,103.

    13F-HR 0001855655-26-000011 filed by Paradigm Biocapital Advisors LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 2,562,154 shares
    Change vs previous 13F -103,544 shares

    5.62% of the 13F portfolio, value $209,789,170.

    13F-HR 0001855655-26-000003 filed by Paradigm Biocapital Advisors LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 2,665,698 shares
    Change vs previous 13F -310,401 shares

    4.69% of the 13F portfolio, value $158,422,432.

    13F-HR 0001855655-25-000014 filed by Paradigm Biocapital Advisors LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 2,976,099 shares
    Change vs previous 13F +365,902 shares

    5.15% of the 13F portfolio, value $120,561,770.

    13F-HR 0001855655-25-000010 filed by Paradigm Biocapital Advisors LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-03-31
    13F 2,610,197 shares
    Change vs previous 13F +78,301 shares

    6.17% of the 13F portfolio, value $134,085,820.

    13F-HR 0001855655-25-000007 filed by Paradigm Biocapital Advisors LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2024-12-31
    13F 2,531,896 shares
    Change vs previous 13F +91,451 shares

    4.88% of the 13F portfolio, value $140,191,082.

    13F-HR 0001855655-25-000004 filed by Paradigm Biocapital Advisors LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2024-09-30
    13F 2,440,445 shares
    Change vs previous 13F not available

    2.81% of the 13F portfolio, value $80,266,236.

    13F-HR 0001855655-24-000014 filed by Paradigm Biocapital Advisors LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).